Raymond James Financial Inc. Acquires Shares of 4,422,760 Haleon plc (NYSE:HLN)

Raymond James Financial Inc. acquired a new stake in shares of Haleon plc (NYSE:HLN - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,422,760 shares of the company's stock, valued at approximately $42,193,000. Raymond James Financial Inc. owned about 0.10% of Haleon as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of HLN. M&T Bank Corp increased its position in Haleon by 6.1% in the fourth quarter. M&T Bank Corp now owns 34,495 shares of the company's stock worth $329,000 after buying an additional 1,993 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in Haleon by 30.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 265,744 shares of the company's stock worth $2,535,000 after buying an additional 62,161 shares in the last quarter. Steward Partners Investment Advisory LLC increased its position in Haleon by 198.6% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 45,523 shares of the company's stock worth $434,000 after buying an additional 30,276 shares in the last quarter. LGT Group Foundation bought a new position in shares of Haleon in the fourth quarter worth about $293,000. Finally, SBI Securities Co. Ltd. bought a new position in shares of Haleon in the fourth quarter worth about $353,000. Hedge funds and other institutional investors own 6.67% of the company's stock.

Haleon Price Performance

Haleon stock traded down $0.04 during midday trading on Friday, reaching $10.16. 8,127,571 shares of the stock traded hands, compared to its average volume of 6,640,348. The stock's fifty day moving average is $9.75 and its 200-day moving average is $9.87. Haleon plc has a 12 month low of $7.89 and a 12 month high of $10.80. The stock has a market cap of $45.97 billion, a P/E ratio of 29.87, a PEG ratio of 2.82 and a beta of 0.25. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44.

Remove Ads

Haleon (NYSE:HLN - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.05 EPS for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The company had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.38 billion. As a group, equities research analysts anticipate that Haleon plc will post 0.43 EPS for the current year.

Haleon Increases Dividend

The business also recently disclosed a -- dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be given a dividend of $0.1166 per share. The ex-dividend date of this dividend is Friday, April 25th. This is an increase from Haleon's previous -- dividend of $0.05. This represents a yield of 1.6%. Haleon's dividend payout ratio is 58.97%.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Haleon in a research note on Monday, March 3rd. Hsbc Global Res lowered Haleon from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, March 5th. Sanford C. Bernstein lowered Haleon from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 8th. HSBC reaffirmed a "hold" rating on shares of Haleon in a research note on Wednesday, March 5th. Finally, Morgan Stanley lowered Haleon from an "overweight" rating to an "equal weight" rating in a research note on Friday, January 10th. Six analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.